Healthcare -
Biotechnology - NASDAQ - US
$ 1.045
-6.7 %
$ 119 M
Market Cap
-0.64
P/E
FATE - OTHER LONG-TERM ASSETS
Other Long-term Assets FATE - Fate Therapeutics, Inc.
15.2 M
LAST VALUE
-63.92%
2 YEAR CAGR
95.93%
5 YEAR CAGR
62.00%
10 YEAR CAGR